HB374 would amend Kentucky’s food misbranding and adulteration laws to specifically address cultured meat, also described in the bill as cultured animal tissue produced from in vitro animal cell cultures outside the organism from which it is derived. The bill adds a new misbranding provision stating that a food is misbranded if it purports to be meat or a meat product and contains cultured animal tissue, and it separately adds a prohibition on the manufacture, sale, or exchange of any meat or meat product containing that tissue.
In practical terms, the bill would place cultured meat products outside the lawful sale of meat and meat products in Kentucky under the state’s food, drug, and cosmetic enforcement framework. It would affect producers, distributors, retailers, and others handling such products by making them subject to existing misbranding and enforcement provisions in KRS Chapter 217. The measure does not create a regulatory approval pathway for cultured meat; instead, it treats those products as prohibited when represented as meat or meat products.
Impact
The bill would amend KRS 217.035 and KRS 217.175 to expressly classify cultured meat as misbranded when sold as meat or a meat product and to prohibit its manufacture, sale, or exchange in Kentucky. This would expand the state’s existing food-labeling and enforcement statutes to cover cell-cultured animal tissue products, giving regulators a clear statutory basis to take action against such products under the misbranding and adulteration provisions already in Chapter 217.
Sentiment
Based on the bill text and the absence of recorded committee transcripts or votes, the available context suggests a straightforward, policy-driven proposal with no documented public debate in the materials provided. The bill’s framing is restrictive and protective of traditional meat definitions, indicating support for limiting cultured meat in the marketplace rather than accommodating it through labeling or regulation. Because no vote history or discussion excerpts are available, there is no recorded evidence here of bipartisan support or organized opposition.
Contention
The central point of contention is likely whether cultured meat should be treated as a legitimate meat product or barred from being marketed as meat at all. Supporters of the bill would likely argue that the term “meat” should be reserved for animal products derived from conventional livestock and that consumers should not be confused by cell-cultured alternatives. Opponents would likely contend that the bill blocks innovation, restricts consumer choice, and creates a categorical ban rather than a labeling standard. No specific stakeholder positions are documented in the provided materials.